Literature DB >> 26298335

Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

Julie K Silver1, Sean R Smith2, Eric M Wisotzky3, Vishwa S Raj4, Jack B Fu5, Rebecca A Kirch6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26298335     DOI： 10.1007/s00520-015-2917-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  1 in total

1.  Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

Authors:  Julie K Silver; Sean R Smith; Eric M Wisotzky; Vishwa S Raj; Jack B Fu; Rebecca A Kirch
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603
  1 in total
  4 in total

1.  Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

Authors:  Julie K Silver; Sean R Smith; Eric M Wisotzky; Vishwa S Raj; Jack B Fu; Rebecca A Kirch
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603

Review 2.  Cancer rehabilitation in Austria--aspects of Physical Medicine and Rehabilitation.

Authors:  Bruno Maehr; Mohammad Keilani; Christoph Wiltschke; Marco Hassler; Thomas Licht; Christine Marosi; Elisabeth Huetterer; Fadime Cenik; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2016-01-12

3.  Cancer rehabilitation and palliative care--two important parts of comprehensive cancer care.

Authors:  Richard Crevenna
Journal:  Support Care Cancer       Date:  2015-10-06       Impact factor: 3.603

4.  Teaching of Independent Exercises for Prehabilitation in Breast Cancer.

Authors:  Jennifer Baima; Sara-Grace Reynolds; Kathryn Edmiston; Anne Larkin; B Marie Ward; Ashling O'Connor
Journal:  J Cancer Educ       Date:  2017-06       Impact factor: 2.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.